{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:48:04Z","timestamp":1778946484292,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"23","license":[{"start":{"date-parts":[[2008,7,24]],"date-time":"2008-07-24T00:00:00Z","timestamp":1216857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,7,24]],"date-time":"2008-07-24T00:00:00Z","timestamp":1216857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1038\/gt.2008.112","type":"journal-article","created":{"date-parts":[[2008,7,24]],"date-time":"2008-07-24T10:58:33Z","timestamp":1216897113000},"page":"1513-1522","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["A novel DNA vaccine-targeting macrophage migration inhibitory factor improves the survival of mice with sepsis"],"prefix":"10.1038","volume":"15","author":[{"given":"S","family":"Tohyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Onodera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Tohyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Nishihira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Mizue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Hamasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,7,24]]},"reference":[{"key":"BFgt2008112_CR1","doi-asserted-by":"publisher","first-page":"4818","DOI":"10.4049\/jimmunol.177.7.4818","volume":"177","author":"ML Toh","year":"2006","unstructured":"Toh ML, Aeberli D, Lacey D, Yang Y, Santos LL, Clarkson M et al. Regulation of IL-1 and TNF receptor expression and function by endogenous macrophage migration inhibitory factor. J Immunol 2006; 177: 4818\u20134825.","journal-title":"J Immunol"},{"key":"BFgt2008112_CR2","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S1286-4579(02)01560-5","volume":"4","author":"H Lue","year":"2002","unstructured":"Lue H, Kleemann R, Calandra T, Roger T, Bernhagen J . Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes Infect 2002; 4: 449\u2013460.","journal-title":"Microbes Infect"},{"key":"BFgt2008112_CR3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/72262","volume":"6","author":"T Calandra","year":"2000","unstructured":"Calandra T, Echtenacher B, Roy DL, Pugin J, Metz CN, Hultner L et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 2000; 6: 164\u2013170.","journal-title":"Nat Med"},{"key":"BFgt2008112_CR4","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/path.1291","volume":"199","author":"KN Lai","year":"2003","unstructured":"Lai KN, Leung JC, Metz CN, Lai FM, Bucala R, Lan HY . Role for macrophage migration inhibitory factor in acute respiratory distress syndrome. J Pathol 2003; 199: 496\u2013508.","journal-title":"J Pathol"},{"key":"BFgt2008112_CR5","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/414920a","volume":"414","author":"T Roger","year":"2001","unstructured":"Roger T, David J, Glauser MP, Calandra T . MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 2001; 414: 920\u2013924.","journal-title":"Nature"},{"key":"BFgt2008112_CR6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0167-5699(00)01680-7","volume":"21","author":"M Clark","year":"2000","unstructured":"Clark M . Antibody humanization: a case of the \u2018Emperor's new clothes\u2019? Immunol Today 2000; 21: 397\u2013402.","journal-title":"Immunol Today"},{"key":"BFgt2008112_CR7","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/art.22407","volume":"56","author":"S Onodera","year":"2007","unstructured":"Onodera S, Ohshima S, Tohyama H, Yasuda K, Nishihira J, Iwakura Y et al. A novel DNA vaccine targeting macrophage migration inhibitory factor protects joints from inflammation and destruction in murine models of arthritis. Arthritis Rheum 2007; 56: 521\u2013530.","journal-title":"Arthritis Rheum"},{"key":"BFgt2008112_CR8","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/nrd1854","volume":"4","author":"JA Buras","year":"2005","unstructured":"Buras JA, Holzmann B, Sitkovsky M . Animal models of sepsis: setting the stage. Nat Rev Drug Discov 2005; 4: 854\u2013865.","journal-title":"Nat Rev Drug Discov"},{"key":"BFgt2008112_CR9","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/0022-4804(90)90260-9","volume":"49","author":"MP Fink","year":"1990","unstructured":"Fink MP, Heard SO . Laboratory models of sepsis and septic shock. J Surg Res 1990; 49: 186\u2013196.","journal-title":"J Surg Res"},{"key":"BFgt2008112_CR10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.4049\/jimmunol.170.1.503","volume":"170","author":"NC Riedemann","year":"2003","unstructured":"Riedemann NC, Neff TA, Guo RF, Bernacki KD, Laudes IJ, Sarma JV et al. Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression. J Immunol 2003; 170: 503\u2013507.","journal-title":"J Immunol"},{"key":"BFgt2008112_CR11","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/0167-5699(91)90142-G","volume":"12","author":"CA Dinarello","year":"1991","unstructured":"Dinarello CA, Thompson RC . Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol Today 1991; 12: 404\u2013410.","journal-title":"Immunol Today"},{"key":"BFgt2008112_CR12","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.4049\/jimmunol.145.9.2920","volume":"145","author":"FP Heinzel","year":"1990","unstructured":"Heinzel FP . The role of IFN-gamma in the pathology of experimental endotoxemia. J Immunol 1990; 145: 2920\u20132924.","journal-title":"J Immunol"},{"key":"BFgt2008112_CR13","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1084\/jem.183.4.1323","volume":"183","author":"MR Dinapoli","year":"1996","unstructured":"Dinapoli MR, Calderon CL, Lopez DM . The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduce expression of the inducible nitric oxide synthase gene. J Exp Med 1996; 183: 1323\u20131329.","journal-title":"J Exp Med"},{"key":"BFgt2008112_CR14","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nm0503-517","volume":"9","author":"NC Riedemann","year":"2003","unstructured":"Riedemann NC, Guo RF, Ward PA . Novel strategies for the treatment of sepsis. Nat Med 2003; 9: 517\u2013524.","journal-title":"Nat Med"},{"key":"BFgt2008112_CR15","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1056\/NEJMra021333","volume":"348","author":"RS Hotchkiss","year":"2003","unstructured":"Hotchkiss RS, Karl IE . The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138\u2013150.","journal-title":"N Engl J Med"},{"key":"BFgt2008112_CR16","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1097\/00003246-200201001-00004","volume":"30","author":"JA Baugh","year":"2002","unstructured":"Baugh JA, Bucala R . Macrophage migration inhibitory factor. Crit Care Med 2002; 30: S27\u2013S35.","journal-title":"Crit Care Med"},{"key":"BFgt2008112_CR17","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1084\/jem.189.2.341","volume":"189","author":"M Bozza","year":"1999","unstructured":"Bozza M, Satoskar AR, Lin G, Lu B, Humbles AA, Gerard C et al. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med 1999; 189: 341\u2013346.","journal-title":"J Exp Med"},{"key":"BFgt2008112_CR18","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/365756a0","volume":"365","author":"J Bernhagen","year":"1993","unstructured":"Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993; 365: 756\u2013759.","journal-title":"Nature"},{"key":"BFgt2008112_CR19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1046\/j.1365-2567.2000.00011.x","volume":"100","author":"N Honma","year":"2000","unstructured":"Honma N, Koseki H, Akasaka T, Nakayama T, Taniguchi M, Serizawa I et al. Deficiency of the macrophage migration inhibitory factor gene has no significant effect on endotoxaemia. Immunology 2000; 100: 84\u201390.","journal-title":"Immunology"},{"key":"BFgt2008112_CR20","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1080\/00365540310016277","volume":"35","author":"T Calandra","year":"2003","unstructured":"Calandra T . Macrophage migration inhibitory factor and host innate immune responses to microbes. Scand J Infect Dis 2003; 35: 573\u2013576.","journal-title":"Scand J Infect Dis"},{"key":"BFgt2008112_CR21","doi-asserted-by":"publisher","first-page":"7271","DOI":"10.1128\/IAI.69.12.7172-7276.2001","volume":"69","author":"B Echtenacher","year":"2001","unstructured":"Echtenacher B, Freudenberg MA, Jack RS, Mannel DN . Differences in innate defense mechanisms in endotoxemia and polymicrobial septic peritonitis. Infect Immun 2001; 69: 7271\u20137276.","journal-title":"Infect Immun"},{"key":"BFgt2008112_CR22","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1172\/JCI200319523","volume":"112","author":"NC Riedemann","year":"2003","unstructured":"Riedemann NC, Guo RF, Ward PA . The enigma of sepsis. J Clin Invest 2003; 112: 460\u2013467.","journal-title":"J Clin Invest"},{"key":"BFgt2008112_CR23","doi-asserted-by":"publisher","first-page":"36541","DOI":"10.1074\/jbc.C500243200","volume":"280","author":"Y Al-Abed","year":"2005","unstructured":"Al-Abed Y, Dabideen D, Aljabari B, Valster A, Messmer D, Ochani M et al. ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis. J Biol Chem 2005; 280: 36541\u201336544.","journal-title":"J Biol Chem"},{"key":"BFgt2008112_CR24","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nm0397-320","volume":"3","author":"SC Donnelly","year":"1997","unstructured":"Donnelly SC, Haslett C, Reid PT, Grant IS, Wallace WA, Metz CN et al. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 1997; 3: 320\u2013323.","journal-title":"Nat Med"},{"key":"BFgt2008112_CR25","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1161\/01.RES.0000168327.22888.4d","volume":"96","author":"F Chagnon","year":"2005","unstructured":"Chagnon F, Metz CN, Bucala R, Lesur O . Endotoxin-induced myocardial dysfunction: effects of macrophage migration inhibitory factor neutralization. Circ Res 2005; 96: 1095\u20131102.","journal-title":"Circ Res"},{"key":"BFgt2008112_CR26","doi-asserted-by":"publisher","first-page":"5998","DOI":"10.4049\/jimmunol.164.11.5998","volume":"164","author":"M Muzio","year":"2000","unstructured":"Muzio M, Bosisio D, Polentarutti N, D\u2019amico G, Stoppacciaro A, Mancinelli R et al. Differential expression and regulation of Toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 2000; 164: 5998\u20136004.","journal-title":"J Immunol"},{"key":"BFgt2008112_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/jcb.20775","volume":"98","author":"DB Lowe","year":"2006","unstructured":"Lowe DB, Shearer MH, Kennedy RC . DNA vaccines: successes and limitations in cancer and infectious disease. J Cell Biochem 2006; 98: 235\u2013242.","journal-title":"J Cell Biochem"},{"key":"BFgt2008112_CR28","doi-asserted-by":"publisher","first-page":"633","DOI":"10.4049\/jimmunol.175.2.633","volume":"175","author":"JJ Donnelly","year":"2005","unstructured":"Donnelly JJ, Wahren B, Liu MA . DNA vaccines: progress and challenges. J Immunol 2005; 175: 633\u2013639.","journal-title":"J Immunol"},{"key":"BFgt2008112_CR29","first-page":"43","volume":"95","author":"JJ Donnelly","year":"1998","unstructured":"Donnelly JJ, Ulmer JB, Liu MA . DNA vaccines. Dev Biol Stand 1998; 95: 43\u201353.","journal-title":"Dev Biol Stand"},{"key":"BFgt2008112_CR30","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1046\/j.1365-3083.1997.d01-139.x","volume":"46","author":"P Jouvenne","year":"1997","unstructured":"Jouvenne P, Fossiez F, Banchereau J, Miossec P . High levels of neutralizing autoantibodies against IL-1 alpha are associated with a better prognosis in chronic polyarthritis: a follow-up study. Scand J Immunol 1997; 46: 413\u2013418.","journal-title":"Scand J Immunol"},{"key":"BFgt2008112_CR31","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/10878","volume":"17","author":"I Dalum","year":"1999","unstructured":"Dalum I, Butler DM, Jensen MR, Hindersson P, Steinaa L, Waterston AM et al. Therapeutic antibodies elicited by immunization against TNF-alpha. Nat Biotechnol 1999; 17: 666\u2013669.","journal-title":"Nat Biotechnol"},{"key":"BFgt2008112_CR32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S1359-6101(03)00004-2","volume":"14","author":"D Zagury","year":"2003","unstructured":"Zagury D, Le Buanec H, Bizzini B, Burny A, Lewis G, Gallo RC . Active versus passive anti-cytokine antibody therapy against cytokine-associated chronic diseases. Cytokine Growth Factor Rev 2003; 14: 123\u2013137.","journal-title":"Cytokine Growth Factor Rev"},{"key":"BFgt2008112_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0925-4439(99)00080-0","volume":"1500","author":"R Abe","year":"2000","unstructured":"Abe R, Shimizu T, Ohkawara A, Nishihira J . Enhancement of macrophage migration inhibitory factor (MIF) expression in injured epidermis and cultured fibroblasts. Biochim Biophys Acta 2000; 1500: 1\u20139.","journal-title":"Biochim Biophys Acta"},{"key":"BFgt2008112_CR34","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1126\/science.285.5425.248","volume":"285","author":"H Wang","year":"1999","unstructured":"Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285: 248\u2013251.","journal-title":"Science"},{"key":"BFgt2008112_CR35","doi-asserted-by":"publisher","first-page":"5616","DOI":"10.4049\/jimmunol.176.9.5616","volume":"176","author":"ZH Nemeth","year":"2006","unstructured":"Nemeth ZH, Csoka B, Wilmanski J, Xu D, Lu Q, Ledent C et al. Adenosine A2A receptor inactivation increases survival in polymicrobial sepsis. J Immunol 2006; 176: 5616\u20135626.","journal-title":"J Immunol"},{"key":"BFgt2008112_CR36","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nri1269","volume":"4","author":"PA Ward","year":"2004","unstructured":"Ward PA . The dark side of C5a in sepsis. Nat Rev Immunol 2004; 4: 133\u2013142.","journal-title":"Nat Rev Immunol"},{"key":"BFgt2008112_CR37","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/nbt0998-867","volume":"16","author":"H Aihara","year":"1998","unstructured":"Aihara H, Miyazaki J . Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 1998; 16: 867\u2013870.","journal-title":"Nat Biotechnol"},{"key":"BFgt2008112_CR38","first-page":"397","volume":"5","author":"Y Mizue","year":"2000","unstructured":"Mizue Y, Nishihira J, Miyazaki T, Fujiwara S, Chida M, Nakamura K et al. Quantitation of macrophage migration inhibitory factor (MIF) using the one-step sandwich enzyme immunosorbent assay: elevated serum MIF concentrations in patients with autoimmune diseases and identification of MIF in erythrocytes. Int J Mol Med 2000; 5: 397\u2013403.","journal-title":"Int J Mol Med"},{"key":"BFgt2008112_CR39","doi-asserted-by":"publisher","first-page":"G695","DOI":"10.1152\/ajpgi.00152.2005","volume":"290","author":"M Overhaus","year":"2006","unstructured":"Overhaus M, Moore BA, Barbato JE, Behrendt FF, Doering JG, Bauer AJ . Biliverdin protects against polymicrobial sepsis by modulating inflammatory mediators. Am J Physiol Gastrointest Liver Physiol 2006; 290: G695\u2013G703.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFgt2008112_CR40","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2144\/05391RV01","volume":"39","author":"ML Wong","year":"2005","unstructured":"Wong ML, Medrano JF . Real-time PCR for mRNA quantitation. Biotechniques 2005; 39: 75\u201385.","journal-title":"Biotechniques"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt2008112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt2008112","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt2008112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T09:21:29Z","timestamp":1684488089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt2008112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,24]]},"references-count":40,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["BFgt2008112"],"URL":"https:\/\/doi.org\/10.1038\/gt.2008.112","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,24]]},"assertion":[{"value":"29 November 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}